<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0152568</article-id>
<article-id pub-id-type="publisher-id">PONE-D-15-51638</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research design</subject><subj-group><subject>Prospective studies</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research design</subject><subj-group><subject>Retrospective studies</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Women's health</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research assessment</subject><subj-group><subject>Systematic reviews</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Hyperlipidemia</subject><subj-group><subject>Hypercholesterolemia</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Hyperlipidemia</subject><subj-group><subject>Hypercholesterolemia</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Cardiovascular medicine</subject><subj-group><subject>Cardiovascular diseases</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Lipids</subject><subj-group><subject>Cholesterol</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Cholesterol as a Risk Factor for Subarachnoid Hemorrhage: A Systematic Review</article-title>
<alt-title alt-title-type="running-head">Cholesterol and Subarachnoid Hemorrhage</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Lindbohm</surname>
<given-names>Joni Valdemar</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kaprio</surname>
<given-names>Jaakko</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Korja</surname>
<given-names>Miikka</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Public Health, University of Helsinki, P.O. Box 41, FI-00014, Helsinki, Finland</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Neurosurgery, University of Helsinki and Helsinki University Hospital, P.O. Box 266, FI-00029, Helsinki, Finland</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>National Institute for Health and Welfare, P.O. Box 30, FI-00271, Helsinki, Finland</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Institute for Molecular Medicine FIMM, P.O. Box 20, FI-00014, Helsinki, Finland</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Quinn</surname>
<given-names>Terence J</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Glasgow, UNITED KINGDOM</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: JVL JK MK. Performed the experiments: JVL JK MK. Analyzed the data: JVL JK MK. Contributed reagents/materials/analysis tools: JVL JK MK. Wrote the paper: JVL JK MK. Did the literature search and the data collection: JVL MK.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">joni.lindbohm@helsinki.fi</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>4</issue>
<elocation-id>e0152568</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>1</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>3</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Lindbohm et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0152568"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>The role played by total cholesterol (TC) in risk for subarachnoid hemorrhage (SAH) is unclear because studies report both high and low TC each as a risk factor. We performed a systematic review to clarify associations between lipid profile and SAH.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>Our literature search comprised Pubmed, Scopus, and Cochrane Library databases with no language, publication year, or study type limitations. The Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA) checklist guided our reporting. Data forms adapted from the Critical Appraisal Skills Program (CASP), and Cochrane Collaboration guidelines provided a platform for risk-of-bias evaluation. We used a random effects model to calculate pooled estimates and assessed heterogeneity with I<sup>2</sup>-statistics.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Of the final 21 studies reviewed, 12 were prospective and 9 retrospective. All studies assessed TC, four assessed HDL, and none LDL in risk for SAH. Heterogeneity among all, retrospective, and Asian studies was high (I<sup>2</sup> = 79.5%, I<sup>2</sup> = 89.0%, and I<sup>2</sup> = 84.3%) and considerable in prospective (I<sup>2</sup> = 46.0%). We therefore focused on qualitative analysis and found that only two studies had a low risk of bias. According to these studies high TC increases risk for SAH in men, whereas the role of HDL remained unclear.</p>
</sec>
<sec id="sec004">
<title>Conclusion</title>
<p>The low-risk-of-bias studies suggest that elevated TC levels elevate risk for SAH in men. Due to the high prevalence of hypercholesterolemia, population attributable risk (PAR) of hypercholesterolemia may exceed the PARs of smoking and hypertension in men. Apart from diabetes and obesity, the risk-factor profile of SAH seems to resemble that of other cerebrovascular diseases, at least in men.</p>
</sec>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>University of Helsinki</institution>
</funding-source>
<principal-award-recipient>
<name name-style="western">
<surname>Lindbohm</surname>
<given-names>Joni Valdemar</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>The authors have no support or funding to report.</funding-statement>
</funding-group>
<counts>
<fig-count count="2"/>
<table-count count="4"/>
<page-count count="15"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are available in the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Epidemiological studies of risk factors of subarachnoid hemorrhage (SAH) are challenging to conduct for a number of reasons, such as relatively young age at diagnosis, low overall incidence of disease, and high death-rate from the first bleed. The latter implies that outside-hospital deaths from SAH are comprehensively diagnosed only in countries with a high coverage of forensic autopsies for sudden deaths. The number of large, long-term, and population-based prospective studies on risk factors for SAH is limited.[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>] According to these studies, the most important risk factors for SAH are smoking, hypertension, female sex, and increasing age.[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>]</p>
<p>The role of total cholesterol (TC) in risk for SAH is conflicting, since studies report both high[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>–<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] and low[<xref ref-type="bibr" rid="pone.0152568.ref007">7</xref>–<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>] TC to raise risk. Meta-analyses[<xref ref-type="bibr" rid="pone.0152568.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0152568.ref015">15</xref>] suggest no association between TC and SAH, whereas they imply that high HDL is protective against SAH. The reviews do not include, however, a number of studies, such as a recent large study suggesting that high TC levels (&gt;6.22 mmol/l) associate with future SAH in men.[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>] As blood lipid levels and especially high levels of low-density lipoprotein (LDL) are important risk factors for cardiovascular diseases in general,[<xref ref-type="bibr" rid="pone.0152568.ref016">16</xref>] we reviewed current evidence on the role of TC and lipoproteins as risk factors for SAH. In contrast to the preceding reviews,[<xref ref-type="bibr" rid="pone.0152568.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0152568.ref015">15</xref>] ours also focuses in depth on methodological quality of the studies reviewed. Readers should note that M.K. and J.K. have published one of the studies reviewed. [<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>]</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec007">
<title>Literature search</title>
<p>The protocol of this study is available in PROSPERO (International prospective register of systematic reviews, registration code: CRD42015016347) and follows the Preferred Reporting Items for Systematic reviews and Meta-analyses for Protocols Statement (PRISMA-P). The authors J.V.L. and M.K. did all steps of the protocol below; discussion with third-author J.K. resolved disagreements. We performed the literature search in two parts using Cochrane Library, Pubmed, and Scopus databases with no language limitations “<xref ref-type="supplementary-material" rid="pone.0152568.s003">S1 Methods</xref>”. As we included non-English-language publications, native speakers assisted when necessary. We included all studies reporting effect estimates with a minimum of two categories for TC, LDL, HDL, or apolipoprotein concentrations. Depending on the design, we divided all studies into either prospective or retrospective to facilitate risk-of-bias evaluations. After reviewing risk-of-bias guidelines from the Cochrane Collaboration Handbook,[<xref ref-type="bibr" rid="pone.0152568.ref017">17</xref>] Critical Appraisal Skills Program (CASP),[<xref ref-type="bibr" rid="pone.0152568.ref018">18</xref>] Newcastle-Ottawa scale,[<xref ref-type="bibr" rid="pone.0152568.ref019">19</xref>] and a measurement tool for assessment of multiple systematic reviews (AMSTAR) [<xref ref-type="bibr" rid="pone.0152568.ref020">20</xref>]we based our risk-of-bias estimations to Cochrane Collaboration Handbook [<xref ref-type="bibr" rid="pone.0152568.ref017">17</xref>] and CASP [<xref ref-type="bibr" rid="pone.0152568.ref018">18</xref>].</p>
<p>We used the PRISMA checklist[<xref ref-type="bibr" rid="pone.0152568.ref021">21</xref>] as a guide to achieve the accepted standards for reporting systematic reviews. Based on the Cochrane Collaborations guidelines,[<xref ref-type="bibr" rid="pone.0152568.ref017">17</xref>] we classified risk of bias into high, unclear, and low-grade categories. Our review focused especially on measurement bias, selection bias, reporting bias, confounder adjustment, reverse causality, and statistical power.</p>
</sec>
<sec id="sec008">
<title>Statistical analysis</title>
<p>Based on the Cox proportional hazards model, we estimated sufficient sample size for prospective follow-up studies. We used a standard significance value of p&lt;0.05, standard power value of P = 0.8, and incidence value of 20/100 000. For optimistic power analysis, we selected the hazard ratio (HR) 2.0 (95% CI 1.0–4.0) as effect size with a wide confidence interval and low correlation factor value of 0.1 between covariates. We used a random effects model to calculate pooled estimates and assessed heterogeneity with I<sup>2</sup>-statistics. For two studies,[<xref ref-type="bibr" rid="pone.0152568.ref007">7</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>] we inverted the reference category in order to present comparable results. Population attributable risk (PAR) was calculated with following formula: PAR = p<sub>f</sub> (RR-1)/[p<sub>f</sub> (RR-1)+1], where p<sub>f</sub> is population fraction with hypercholesterolemia. Stata statistical software version 12.1 Stata Corp performed all the calculations.</p>
</sec>
</sec>
<sec id="sec009" sec-type="results">
<title>Results</title>
<sec id="sec010">
<title>General</title>
<sec id="sec011">
<title>Search results</title>
<p>In brief, 21 studies[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>–<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] including ≥50 SAH cases emerged that reported associations between risk for SAH and TC levels “<xref ref-type="fig" rid="pone.0152568.g001">Fig 1</xref>”.</p>
<fig id="pone.0152568.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0152568.g001</object-id>
<label>Fig 1</label>
<caption>
<title>PRISMA Flow diagram.</title>
<p>Study selection protocol.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0152568.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec012">
<title>Cohort characteristics</title>
<p>Cohort sizes and follow-up times in prospective studies differed considerably, and the number of SAH ranged from 55[<xref ref-type="bibr" rid="pone.0152568.ref028">28</xref>] to 437[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>] (<xref ref-type="table" rid="pone.0152568.t001">Table 1</xref>). In the retrospective studies, the number of SAHs ranged from 95[<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>] to 858.[<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>] The reported mean or median age at SAH in all studies ranged from 46.9[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>] to 64[<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>] years (<xref ref-type="table" rid="pone.0152568.t001">Table 1</xref>). Supplementary file “<xref ref-type="supplementary-material" rid="pone.0152568.s001">S1 Cohorts</xref>” describes the data collection in all 12 prospective studies in detail.</p>
<table-wrap id="pone.0152568.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0152568.t001</object-id>
<label>Table 1</label> <caption><title>Study characteristics.</title> <p>Summary of study characteristics and differences between prospective and retrospective studies.</p></caption>
<alternatives>
<graphic id="pone.0152568.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0152568.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Authors and Country</th>
<th align="center">Year</th>
<th align="center">Size</th>
<th align="center">Age</th>
<th align="center">% of men</th>
<th align="center">Median/mean Follow-up</th>
<th align="center">SAH cases</th>
<th align="center">Fatal or non-fatal SAHs included</th>
<th align="center">Outside-hospital deaths included</th>
<th align="center">Median/mean age at SAH</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="2"><bold>Prospective studies</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="right"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Finland</bold></td>
<td align="left"/>
<td align="left"/>
<td align="right"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="right"/>
<td align="right"/>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Knekt</bold> [<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>]</td>
<td align="center">1991</td>
<td align="center">42 862</td>
<td align="center">20–69</td>
<td align="center">54</td>
<td align="center">12</td>
<td align="center">187</td>
<td align="center">Both</td>
<td align="center">Yes</td>
<td align="center">46.9</td>
</tr>
<tr>
<td align="center"><bold>Korja</bold> [<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>]</td>
<td align="center">2013</td>
<td align="center">64 349</td>
<td align="center">25–74</td>
<td align="center">48.3</td>
<td align="center">17.9</td>
<td align="center">437</td>
<td align="center">Both</td>
<td align="center">Yes</td>
<td align="center">59.3</td>
</tr>
<tr>
<td align="center"><bold>Leppälä</bold> [<xref ref-type="bibr" rid="pone.0152568.ref029">29</xref>]</td>
<td align="center">1999</td>
<td align="center">28 519</td>
<td align="center">50–69</td>
<td align="center">100</td>
<td align="center">6</td>
<td align="center">85</td>
<td align="center">Both</td>
<td align="center">Yes</td>
<td align="center">NR</td>
</tr>
<tr>
<td align="center"><bold>Zhang</bold> [<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>]</td>
<td align="center">2012</td>
<td align="center">58 235</td>
<td align="center">25–74</td>
<td align="center">47.6</td>
<td align="center">20.1</td>
<td align="center">332</td>
<td align="center">Both</td>
<td align="center">Yes</td>
<td align="center">NR</td>
</tr>
<tr>
<td align="center"><bold>Japan</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Cui</bold> [<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>]</td>
<td align="center">2007</td>
<td align="center">38 158</td>
<td align="center">40–79</td>
<td align="center">38</td>
<td align="center">10</td>
<td align="center">66</td>
<td align="center">Fatal</td>
<td align="center">NR</td>
<td align="center">61.9</td>
</tr>
<tr>
<td align="center"><bold>Suzuki</bold> [<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>]</td>
<td align="center">2011</td>
<td align="center">156 892</td>
<td align="center">30–89</td>
<td align="center">48.7</td>
<td align="center">3</td>
<td align="center">223</td>
<td align="center">Both</td>
<td align="center">No</td>
<td align="center">NR</td>
</tr>
<tr>
<td align="center"><bold>Norway</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Sandvei</bold> [<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>]</td>
<td align="center">2012</td>
<td align="center">92 682</td>
<td align="center">20–90+</td>
<td align="center">33.6</td>
<td align="center">10.9</td>
<td align="center">122</td>
<td align="center">Both</td>
<td align="center">Yes</td>
<td align="center">58.9</td>
</tr>
<tr>
<td align="center"><bold>South Korea</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Suh</bold> [<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>]</td>
<td align="center">2001</td>
<td align="center">114 793</td>
<td align="center">35–59</td>
<td align="center">100</td>
<td align="center">6</td>
<td align="center">98</td>
<td align="center">Both</td>
<td align="center">No</td>
<td align="center">NR</td>
</tr>
<tr>
<td align="center"><bold>Sweden</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Gatchev</bold> [<xref ref-type="bibr" rid="pone.0152568.ref007">7</xref>]</td>
<td align="center">1993</td>
<td align="center">54 385</td>
<td align="center">25–74</td>
<td align="center">40.1</td>
<td align="center">20.5</td>
<td align="center">87</td>
<td align="center">Fatal</td>
<td align="center">NR</td>
<td align="center">NR</td>
</tr>
<tr>
<td align="center"><bold>USA</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Iso</bold> [<xref ref-type="bibr" rid="pone.0152568.ref028">28</xref>] <xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="center">1989</td>
<td align="center">350 977</td>
<td align="center">35–57</td>
<td align="center">100</td>
<td align="center">6</td>
<td align="center">55</td>
<td align="center">Fatal</td>
<td align="center">No</td>
<td align="center">47.4</td>
</tr>
<tr>
<td align="center"><bold>Neaton</bold> [<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>] <xref ref-type="table-fn" rid="t001fn001">*</xref>,<xref ref-type="table-fn" rid="t001fn002">†</xref></td>
<td align="center">1993</td>
<td align="center">353 340</td>
<td align="center">35–57</td>
<td align="center">100</td>
<td align="center">25</td>
<td align="center">259</td>
<td align="center">Fatal</td>
<td align="center">No</td>
<td align="center">47.2</td>
</tr>
<tr>
<td align="center"><bold>Tirschwell</bold> [<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>]</td>
<td align="center">2004</td>
<td align="center">8 010</td>
<td align="center">30–79</td>
<td align="center">44.2</td>
<td align="center">11</td>
<td align="center">96</td>
<td align="center">Both</td>
<td align="center">NR</td>
<td align="center">N/A<xref ref-type="table-fn" rid="t001fn003">‡</xref></td>
</tr>
<tr>
<td align="center" colspan="2"><bold>Retrospective</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Great Britain &amp; Denmark</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Adamson</bold> [<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>]</td>
<td align="center">1994</td>
<td align="center">189</td>
<td align="center">25–70</td>
<td align="center">44.8</td>
<td align="center">N/A</td>
<td align="center">96</td>
<td align="center">NR</td>
<td align="center">No</td>
<td align="center">48</td>
</tr>
<tr>
<td align="center"><bold>Japan</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Inagawa</bold> [<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>]</td>
<td align="center">2005</td>
<td align="center">494</td>
<td align="center">25–96</td>
<td align="center">43.7</td>
<td align="center">N/A</td>
<td align="center">247</td>
<td align="center">Both</td>
<td align="center">No</td>
<td align="center">62.6</td>
</tr>
<tr>
<td align="center"><bold>Inagawa</bold> [<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>]</td>
<td align="center">2010</td>
<td align="center">1 941</td>
<td align="center">31–89</td>
<td align="center">35</td>
<td align="center">N/A</td>
<td align="center">858</td>
<td align="center">Both</td>
<td align="center">NR</td>
<td align="center">64</td>
</tr>
<tr>
<td align="center"><bold>Ohkuma</bold> [<xref ref-type="bibr" rid="pone.0152568.ref010">10</xref>]</td>
<td align="center">2003</td>
<td align="center">780</td>
<td align="center">25–85≤</td>
<td align="center">31</td>
<td align="center">N/A</td>
<td align="center">390</td>
<td align="center">NR</td>
<td align="center">No</td>
<td align="center">58</td>
</tr>
<tr>
<td align="center"><bold>Tokuda</bold> [<xref ref-type="bibr" rid="pone.0152568.ref011">11</xref>]</td>
<td align="center">2005</td>
<td align="center">300</td>
<td align="center">24–95</td>
<td align="center">29</td>
<td align="center">N/A</td>
<td align="center">150</td>
<td align="center">NR</td>
<td align="center">No</td>
<td align="center">60</td>
</tr>
<tr>
<td align="center"><bold>Holland</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Vlak</bold> [<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>]</td>
<td align="center">2013</td>
<td align="center">824</td>
<td align="center">54.8 (15.8)<xref ref-type="table-fn" rid="t001fn004">§</xref></td>
<td align="center">29</td>
<td align="center">N/A</td>
<td align="center">250</td>
<td align="center">Non-fatal</td>
<td align="center">No</td>
<td align="center">54.7</td>
</tr>
<tr>
<td align="center"><bold>Portugal</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Canhao</bold> [<xref ref-type="bibr" rid="pone.0152568.ref026">26</xref>]</td>
<td align="center">1994</td>
<td align="center">423</td>
<td align="center">&lt;40–65&lt;</td>
<td align="center">30.5</td>
<td align="center">N/A</td>
<td align="center">141</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
</tr>
<tr>
<td align="center"><bold>South Korea</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Park</bold> [<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>]</td>
<td align="center">1998</td>
<td align="center">464 II</td>
<td align="center">21–86</td>
<td align="center">48.1</td>
<td align="center">N/A</td>
<td align="center">95</td>
<td align="center">Both</td>
<td align="center">NR</td>
<td align="center">51.7</td>
</tr>
<tr>
<td align="center"><bold>USA</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Broderick</bold> [<xref ref-type="bibr" rid="pone.0152568.ref023">23</xref>]</td>
<td align="center">2003</td>
<td align="center">930</td>
<td align="center">19–49</td>
<td align="center">39</td>
<td align="center">N/A</td>
<td align="center">312</td>
<td align="center">Non-fatal</td>
<td align="center">No</td>
<td align="center">NR</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>*90.1% European. 6.4% African-American. 4.5% Hispanic or Oriental origin</p></fn>
<fn id="t001fn002"><p><sup>†</sup>Includes all SAH deaths through 1999 as additional data</p></fn>
<fn id="t001fn003"><p><sup>‡</sup> Mean reported only for hemorrhagic stroke category</p></fn>
<fn id="t001fn004"><p><sup>§</sup> Standard deviation</p></fn>
<fn id="t001fn005"><p>II 102 intra cranial hemorrhages included in the number</p></fn>
<fn id="t001fn006"><p>NR = not reported. N/A = not applicable</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec013">
<title>Cases</title>
<p>Eight prospective[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0152568.ref029">29</xref>,<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] and three[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>] retrospective studies comprised both fatal and none-fatal SAHs. Five[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0152568.ref029">29</xref>] prospective studies (all Finnish or Norwegian) also reported inclusion of outside hospital deaths (<xref ref-type="table" rid="pone.0152568.t001">Table 1</xref>). Diagnosis-verification protocol (computed tomography or lumbar puncture) was sufficient in all studies.</p>
</sec>
</sec>
<sec id="sec014">
<title>Total cholesterol</title>
<sec id="sec015">
<title>Associations in prospective studies</title>
<p>Of the 12 studies,[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>–<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>–<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] two[<xref ref-type="bibr" rid="pone.0152568.ref007">7</xref>,<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>] suggested that low TC elevated risk for SAH (<xref ref-type="table" rid="pone.0152568.t002">Table 2</xref>). The Swedish study observed, without having data on smoking, that low TC in men elevated SAH risk with a relative risk (RR) of 3.43 (<xref ref-type="table" rid="pone.0152568.t002">Table 2</xref>).[<xref ref-type="bibr" rid="pone.0152568.ref007">7</xref>] The Japanese hospital-based cohort study reported that high TC lowered SAH risk with varying RRs 0.2–0.5 in low vs high analysis (no dose-response reported) including men and women with all their values above 4.14 mmol/l (<xref ref-type="table" rid="pone.0152568.t002">Table 2</xref>).[<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>]</p>
<table-wrap id="pone.0152568.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0152568.t002</object-id>
<label>Table 2</label> <caption><title>Associations between TC and SAH.</title> <p>Associations between TC levels and SAH, number of SAHs in the subgroup analyses, and type of TC measurement with control group.</p></caption>
<alternatives>
<graphic id="pone.0152568.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0152568.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Authors and country</th>
<th align="center">Lowest vs highest or vice versa (mmol/l)</th>
<th align="center">HR/RR/OR and 95% CIs</th>
<th align="center">No. of SAHs among men</th>
<th align="center">No. of male cases in highest category</th>
<th align="center">No. of SAHs among women</th>
<th align="center">No. of female cases in highest category</th>
<th align="center">Cases´ TC measurement and type of cohort or control group</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><bold>Prospective</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left"><bold>Finland</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Knekt</bold> [<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>]</td>
<td align="center">≤5.96 vs 6.99&lt;</td>
<td align="center">M 0.9 (0.6–1.5) W 1.0 (0.6–1.8)</td>
<td align="center">102</td>
<td align="center">39</td>
<td align="center">85</td>
<td align="center">39</td>
<td align="center">sB, PB</td>
</tr>
<tr>
<td align="center"><bold>Korja</bold> [<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>]</td>
<td align="center">&lt;4.92 vs 7.07&lt;</td>
<td align="left">M 2.18 (1.19–4.00) W 0.99 (0.62–1.59)</td>
<td align="center">206</td>
<td align="center">58</td>
<td align="center">231</td>
<td align="center">60</td>
<td align="center">sB, PB</td>
</tr>
<tr>
<td align="center"><bold>Leppälä</bold> [<xref ref-type="bibr" rid="pone.0152568.ref029">29</xref>]</td>
<td align="center">&lt;4.90 vs 7.00≤</td>
<td align="center">0.78 (0.38–1.62)</td>
<td align="center">85</td>
<td align="center">19</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">B, MS</td>
</tr>
<tr>
<td align="center"><bold>Zhang</bold> [<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>]</td>
<td align="center">&lt;5.00 vs 7.00&lt;</td>
<td align="center">M 1.79 (1.00–3.19) W 1.25 (0.71–2.20)</td>
<td align="center">151</td>
<td align="center">49</td>
<td align="center">181</td>
<td align="center">46</td>
<td align="center">sB, PB</td>
</tr>
<tr>
<td align="left"><bold>Japan</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Cui</bold> [<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>]</td>
<td align="center">&lt;4.14 vs 7.22≤</td>
<td align="center">0.60 (0.08–4.73)</td>
<td align="center">25</td>
<td align="center">NR</td>
<td align="center">41</td>
<td align="center">NR</td>
<td align="center">nB, PB</td>
</tr>
<tr>
<td align="center"><bold>Suzuki</bold> [<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>]</td>
<td align="center">&lt;4.14 vs 7.24≤</td>
<td align="center">0.2 (0.0–0.8)</td>
<td align="center">89</td>
<td align="center">NR</td>
<td align="center">134</td>
<td align="center">NR</td>
<td align="center">B, H</td>
</tr>
<tr>
<td align="left"><bold>Norway</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Sandvei</bold> [<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>]</td>
<td align="center">5.9, per SD (1.3)</td>
<td align="center">0.9 (0.7–1.1)</td>
<td align="center">41</td>
<td align="center">NR</td>
<td align="center">81</td>
<td align="center">NR</td>
<td align="center">nB, PB</td>
</tr>
<tr>
<td align="left"><bold>South Korea</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Suh</bold> [<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>] <xref ref-type="table-fn" rid="t002fn004">§</xref></td>
<td align="center">&lt;4.31 vs 5.70&lt;</td>
<td align="center">0.69 (0.37–1.32)</td>
<td align="center">98</td>
<td align="center">18</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">fB, CP</td>
</tr>
<tr>
<td align="left"><bold>Sweden</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Gatchev</bold> [<xref ref-type="bibr" rid="pone.0152568.ref007">7</xref>] <xref ref-type="table-fn" rid="t002fn004">§</xref></td>
<td align="center">M 5.3 vs 7.6 W 5.4 vs 7.9</td>
<td align="left">M 0.29 (0.10–0.89) W 0.98 (0.42–2.08)</td>
<td align="center">37</td>
<td align="center">4</td>
<td align="center">50</td>
<td align="center">12</td>
<td align="center">nB, PB</td>
</tr>
<tr>
<td align="left"><bold>USA</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Iso</bold> [<xref ref-type="bibr" rid="pone.0152568.ref028">28</xref>]</td>
<td align="center">&lt;4.14 vs 7.24≤</td>
<td align="center">0.16 <xref ref-type="table-fn" rid="t002fn002">*</xref></td>
<td align="center">55</td>
<td align="center">1</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">nB, IG</td>
</tr>
<tr>
<td align="center"><bold>Neaton</bold> [<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>]</td>
<td align="center">&lt;4.14 vs 7.24≤</td>
<td align="center">1.70 (0.76–3.83)</td>
<td align="center">259</td>
<td align="center">17</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">nB, IG</td>
</tr>
<tr>
<td align="center"><bold>Tirschwell</bold> [<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>]</td>
<td align="center">4.45 vs 7.50 <xref ref-type="table-fn" rid="t002fn003">†</xref></td>
<td align="center">1.3 (0.7–2.4)</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">B, HM</td>
</tr>
<tr>
<td align="left"><bold>Retrospective</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left" colspan="2"><bold>Great Britain &amp; Denmark</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Adamson</bold> [<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>]</td>
<td align="center">&lt;5.40 vs 6.30&lt;</td>
<td align="center">15.7 (2.8–89)</td>
<td align="center">43</td>
<td align="center">NR</td>
<td align="center">53</td>
<td align="center">NR</td>
<td align="center">aB, HE</td>
</tr>
<tr>
<td align="left"><bold>Japan</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Inagawa</bold> [<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>]</td>
<td align="center">&lt;5.69 vs 5.69&lt;</td>
<td align="center">M 2.18 (0.67–7.08) W 4.08 (1.59–10.46)</td>
<td align="center">108</td>
<td align="center">18</td>
<td align="center">139</td>
<td align="center">48</td>
<td align="center">aB, HE</td>
</tr>
<tr>
<td align="center"><bold>Inagawa</bold> [<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>]</td>
<td align="center">&lt;5.69 vs 5.69&lt;</td>
<td align="center">M 0.89 (0.50–1.60) W 0.73 (0.55–0.98)</td>
<td align="center">276</td>
<td align="center">NR</td>
<td align="center">522</td>
<td align="center">NR</td>
<td align="center">aB, HC</td>
</tr>
<tr>
<td align="center"><bold>Ohkuma</bold> [<xref ref-type="bibr" rid="pone.0152568.ref010">10</xref>]</td>
<td align="center">NR</td>
<td align="center">0.41 (0.24–0.71)</td>
<td align="center">119</td>
<td align="center">NR</td>
<td align="center">271</td>
<td align="center">NR</td>
<td align="center">I, HE</td>
</tr>
<tr>
<td align="center"><bold>Tokuda</bold> [<xref ref-type="bibr" rid="pone.0152568.ref011">11</xref>]</td>
<td align="center">&lt;5.20 vs 5.20&lt;</td>
<td align="center">0.22 (0.12–0.40)</td>
<td align="center">43</td>
<td align="center">NR</td>
<td align="center">107</td>
<td align="center">NR</td>
<td align="center">aB, H</td>
</tr>
<tr>
<td align="left"><bold>Holland</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Vlak</bold> [<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>]</td>
<td align="center">NR</td>
<td align="center">0.2 (0.1–0.4)</td>
<td align="center">62</td>
<td align="center">NR</td>
<td align="center">188</td>
<td align="center">NR</td>
<td align="center">I, HC</td>
</tr>
<tr>
<td align="left"><bold>Portugal</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Canhao</bold> [<xref ref-type="bibr" rid="pone.0152568.ref026">26</xref>]</td>
<td align="center">&lt;6.21 vs 6.21&lt;</td>
<td align="center">0.9 (0.5–1.7)</td>
<td align="center">95</td>
<td align="center">27</td>
<td align="center">46</td>
<td align="center">67</td>
<td align="center">I, HC</td>
</tr>
<tr>
<td align="center"><bold>Park</bold> [<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>]</td>
<td align="center">&lt;3.88 vs 4.9&lt;</td>
<td align="center">1.02 (1.01–1.02)</td>
<td align="center">24</td>
<td align="center">NR</td>
<td align="center">71</td>
<td align="center">NR</td>
<td align="center">aB, A</td>
</tr>
<tr>
<td align="left"><bold>USA</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Broderick</bold> [<xref ref-type="bibr" rid="pone.0152568.ref023">23</xref>]</td>
<td align="center">NR</td>
<td align="center">0.53</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">I, HE</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>M = men, W = women, A = acute patients, B = blood sample with no fasting information, aB = blood sample on admission, fB = fasting blood sample, nB = non-fasting blood sample, sB = semi-fasting blood sample, CP = male civil service and private school workers, H = hospital based, HC = health check-up, HE = healthy, HM = hypertensive men and menopausal women, I = interview, IG = industry-company workers or government staff, MS = male smokers, PB = population based, NR = not reported</p></fn>
<fn id="t002fn002"><p>*Not significant and CIs not provided</p></fn>
<fn id="t002fn003"><p><sup>†</sup> Quintile means</p></fn>
<fn id="t002fn004"><p><sup>§</sup> Reference group inverted in studies of Gatchev and Suh</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Two population-based studies,[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] including also outside hospital deaths, found that elevated TC levels (&gt;5.59 mmol/l, &gt;6.22 mmol/l, and ≥7.07 mmol/l vs ≤4.92 mmol/l[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>] and ≥7.0 mmol/l vs &lt;5.0 mmol/l[<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>]) increased risk for SAH in men with an HR of 1.97[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>], 1.85[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>], 2.18[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>], and 1.79[<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] (<xref ref-type="table" rid="pone.0152568.t002">Table 2</xref>). The other study also reported dose response as a 1 mmol/l increase in TC raised risk for SAH in men with an HR of 1.16.[<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] The remaining eight prospective studies[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>,<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>–<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] found no associations between TC and SAH (<xref ref-type="table" rid="pone.0152568.t002">Table 2</xref>).</p>
</sec>
<sec id="sec016">
<title>Associations in retrospective studies</title>
<p>Of the nine[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0152568.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>,<xref ref-type="bibr" rid="pone.0152568.ref026">26</xref>] studies, four[<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>] found that high TC measured by interview[<xref ref-type="bibr" rid="pone.0152568.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>] or on admission (with hospital-based or health check-up control group),[<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0152568.ref011">11</xref>] decreased SAH risk with ORs of 0.2 [<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>], 0.22 [<xref ref-type="bibr" rid="pone.0152568.ref011">11</xref>], 0.41 [<xref ref-type="bibr" rid="pone.0152568.ref010">10</xref>] and (in women only) 0.73 (<xref ref-type="table" rid="pone.0152568.t002">Table 2</xref>).[<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>]</p>
<p>Three[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>] studies with on-admission measurements found that elevated TC (&gt;4.9[<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>], &gt;5.7[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>], &gt;6.3[<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>] mmol/l) elevated risk for SAH (ORs 1.02[<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>], 2.4[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>], 15.7[<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>]) (<xref ref-type="table" rid="pone.0152568.t002">Table 2</xref>). One of these studies also found an increased risk for SAH in women with high TC (&gt;5.7 mmol/l) with an RR of 4.08 (<xref ref-type="table" rid="pone.0152568.t002">Table 2</xref>).[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>] Two[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>] of these three[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>] used mainly healthy controls, and one[<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>] used other acute emergency room patients and their on-admission TC values (<xref ref-type="table" rid="pone.0152568.t002">Table 2</xref>). Two[<xref ref-type="bibr" rid="pone.0152568.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0152568.ref026">26</xref>] studies found no associations between TC and SAH (<xref ref-type="table" rid="pone.0152568.t002">Table 2</xref>).</p>
</sec>
<sec id="sec017">
<title>TC range and power in prospective studies</title>
<p>Nine studies[<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>–<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] included a wide range of TC values, but only three[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>,<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] reported a sufficient sample size (≥31) of male and female SAHs in the high-TC group to determine an HR under 2 (Tables <xref ref-type="table" rid="pone.0152568.t002">2</xref> and <xref ref-type="table" rid="pone.0152568.t003">3</xref>). <xref ref-type="table" rid="pone.0152568.t002">Table 2</xref> and “<xref ref-type="supplementary-material" rid="pone.0152568.s005">S1 Table</xref>” present TC measurement protocols in detail.</p>
<table-wrap id="pone.0152568.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0152568.t003</object-id>
<label>Table 3</label> <caption><title>Sample sizes.</title> <p>Required number of person-years and SAHs for subgroup analysis for different HR values.</p></caption>
<alternatives>
<graphic id="pone.0152568.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0152568.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">HR</th>
<th align="center">SAH in subgroup studied</th>
<th align="center">Person years needed</th>
</tr>
</thead>
<tbody>
<tr>
<td align="char" char=".">1.5</td>
<td align="center">91</td>
<td align="center">452 854</td>
</tr>
<tr>
<td align="char" char=".">1.6</td>
<td align="center">68</td>
<td align="center">337 026</td>
</tr>
<tr>
<td align="char" char=".">1.7</td>
<td align="center">53</td>
<td align="center">264 414</td>
</tr>
<tr>
<td align="char" char=".">1.8</td>
<td align="center">44</td>
<td align="center">215 490</td>
</tr>
<tr>
<td align="char" char=".">1.9</td>
<td align="center">37</td>
<td align="center">180 715</td>
</tr>
<tr>
<td align="char" char=".">2.0</td>
<td align="center">31</td>
<td align="center">154 958</td>
</tr>
<tr>
<td align="char" char=".">2.1</td>
<td align="center">28</td>
<td align="center">135 248</td>
</tr>
<tr>
<td align="char" char=".">2.2</td>
<td align="center">24</td>
<td align="center">119 760</td>
</tr>
<tr>
<td align="char" char=".">2.3</td>
<td align="center">22</td>
<td align="center">107 318</td>
</tr>
<tr>
<td align="char" char=".">2.4</td>
<td align="center">20</td>
<td align="center">97 137</td>
</tr>
<tr>
<td align="char" char=".">2.5</td>
<td align="center">18</td>
<td align="center">88 675</td>
</tr>
<tr>
<td align="char" char=".">2.6</td>
<td align="center">17</td>
<td align="center">81 545</td>
</tr>
<tr>
<td align="char" char=".">2.7</td>
<td align="center">16</td>
<td align="center">75 466</td>
</tr>
<tr>
<td align="char" char=".">2.8</td>
<td align="center">15</td>
<td align="center">70 229</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>p&lt;0.05, P = 0.8, covariate correlation factor 0.1, and incidence 20/100 000</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec018">
<title>TC measurement and range in retrospective studies</title>
<p>Five[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0152568.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>] studies measured TC on admission after SAH and four[<xref ref-type="bibr" rid="pone.0152568.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0152568.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0152568.ref026">26</xref>] by interview. None of the nine[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0152568.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>,<xref ref-type="bibr" rid="pone.0152568.ref026">26</xref>] studies included a wide range of TC values in their analysis (<xref ref-type="table" rid="pone.0152568.t002">Table 2</xref>).</p>
</sec>
<sec id="sec019">
<title>Risk-factor adjustments in prospective studies</title>
<p>All[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>–<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] except one study[<xref ref-type="bibr" rid="pone.0152568.ref007">7</xref>] recorded known SAH risk factors: age, sex, hypertension, and smoking (or comprised only smokers or one sex), and all but two[<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0152568.ref007">7</xref>] controlled for them in a multivariable model. One study reporting high[<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] and one low[<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>] TC as elevating risk for SAH also controlled for BMI values for confounding in analyses. The two studies reporting low TC as elevating risk lacked data on smoking[<xref ref-type="bibr" rid="pone.0152568.ref007">7</xref>] or analysis by sex.[<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>]</p>
</sec>
<sec id="sec020">
<title>Risk-factor adjustments in retrospective studies</title>
<p>All nine[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0152568.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>,<xref ref-type="bibr" rid="pone.0152568.ref026">26</xref>] studies recorded known risk factors for SAH, and the four[<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>] reporting low and the three[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>] high TC as a risk factor for SAH controlled for them all.</p>
</sec>
<sec id="sec021">
<title>Low-TC studies</title>
<p>Five retrospective[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0152568.ref011">11</xref>] and three[<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>] prospective studies came from Japan and South Korea, where TC levels are generally lower than in Western countries. Separate analysis of these studies was still conflicting, since two[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>] reported high and four[<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>–<xref ref-type="bibr" rid="pone.0152568.ref011">11</xref>] low TC as elevating risk, and two[<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>] remained inconclusive (<xref ref-type="table" rid="pone.0152568.t002">Table 2</xref>).</p>
</sec>
<sec id="sec022">
<title>Brief summary of TC findings</title>
<p>Of the 12[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>–<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>–<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] prospective studies, 2[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] found high TC raising risk for SAH in men. Conversely, two prospective studies found low TC as raising risk for SAH in men[<xref ref-type="bibr" rid="pone.0152568.ref007">7</xref>] and in both men and women[<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>] while eight[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>,<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>–<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] were indecisive (<xref ref-type="table" rid="pone.0152568.t002">Table 2</xref>). Of the nine[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0152568.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>,<xref ref-type="bibr" rid="pone.0152568.ref026">26</xref>]retrospective studies, four[<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>] found low and three[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>] high TC as raising risk for SAH whereas the others[<xref ref-type="bibr" rid="pone.0152568.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0152568.ref026">26</xref>] remained inconsistent.</p>
</sec>
</sec>
<sec id="sec023">
<title>Subfractions of cholesterol</title>
<sec id="sec024">
<title>HDL and other lipoproteins</title>
<p>Three[<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0152568.ref029">29</xref>] prospective and one[<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>] retrospective study analyzed associations between HDL and risk for SAH (<xref ref-type="table" rid="pone.0152568.t004">Table 4</xref>). The one[<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>] retrospective also analyzed association of apolipoprotein B (ApoB) with SAH. None of the studies focused on any other lipoprotein subtypes, such as LDL, or the lipid subfractions nowadays available with lipidomic analyses.[<xref ref-type="bibr" rid="pone.0152568.ref031">31</xref>] <xref ref-type="supplementary-material" rid="pone.0152568.s005">S1 Table</xref> presents a detailed summary of different laboratory methods that studies used to analyze HDL.</p>
<table-wrap id="pone.0152568.t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0152568.t004</object-id>
<label>Table 4</label> <caption><title>Associations between HDL and SAH.</title> <p>Associations between HDL levels and SAHs, number of SAHs in subgroup analyses and type of HDL measurement with control group.</p></caption>
<alternatives>
<graphic id="pone.0152568.t004g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0152568.t004" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Authors and Country</th>
<th align="center">Protective factor</th>
<th align="center">Highest vs lowest (mmol/l)</th>
<th align="center">HR/RR/OR and 95% CIs</th>
<th align="center">No. of SAHs among men</th>
<th align="center">No. of male cases in lowest category</th>
<th align="center">No. of SAHs among women</th>
<th align="center">No. of female cases in lowest category</th>
<th align="center">Cases´ TC measurement and type of controls or cohort</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="2"><bold>Prospective</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Finland</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Leppälä</bold> [<xref ref-type="bibr" rid="pone.0152568.ref029">29</xref>]</td>
<td align="center">High HDL</td>
<td align="center">1.45&lt; vs &lt;0.84</td>
<td align="center">0.26 (0.11–0.62)</td>
<td align="center">85</td>
<td align="center">14</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">B, SM</td>
</tr>
<tr>
<td align="center"><bold>Zhang</bold> [<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>]</td>
<td align="center">None</td>
<td align="center">&lt;1.0 vs 1.4&lt;</td>
<td align="center">M 0.56 (0.25–1.25) W 1.27 (0.50–3.28)</td>
<td align="center">151</td>
<td align="center">17</td>
<td align="center">181</td>
<td align="center">15</td>
<td align="center">sB, PB</td>
</tr>
<tr>
<td align="center"><bold>Norway</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Sandvei</bold> [<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>]</td>
<td align="center">None</td>
<td align="center">1.4 (SD 0.4)</td>
<td align="center">1.0 (0.9–1.3)<xref ref-type="table-fn" rid="t004fn002">*</xref></td>
<td align="center">41</td>
<td align="center">NR</td>
<td align="center">81</td>
<td align="center">NR</td>
<td align="center">nB, PB</td>
</tr>
<tr>
<td align="center"><bold>&lt;50 years</bold></td>
<td align="center">High HDL</td>
<td align="center">1.4 (SD 0.4)</td>
<td align="center">0.6 (0.4–0.9)<xref ref-type="table-fn" rid="t004fn002">*</xref></td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>&gt;50 years</bold></td>
<td align="center">Low HDL</td>
<td align="center">1.4 (SD 0.4)</td>
<td align="center">1.2 (1.0–1.5)<xref ref-type="table-fn" rid="t004fn002">*</xref></td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center">NR</td>
<td align="center"/>
</tr>
<tr>
<td align="center" colspan="2"><bold>Retrospective</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left" colspan="3"><bold>Great Britain &amp; Denmark</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="center"><bold>Adamson</bold> [<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>]</td>
<td align="center">None</td>
<td align="center">1.4&lt; vs &lt;1.1</td>
<td align="center">NR</td>
<td align="center">43</td>
<td align="center">NR</td>
<td align="center">53</td>
<td align="center">NR</td>
<td align="center">aB, HE</td>
</tr>
<tr>
<td align="center"><bold>ApoB (g/l)</bold></td>
<td align="center">None</td>
<td align="center">0.83&lt; vs &lt;0.65</td>
<td align="center">1.0 CIs NR</td>
<td align="center">43</td>
<td align="center">NR</td>
<td align="center">53</td>
<td align="center">NR</td>
<td align="center"/>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001"><p>M = men, W = women, B = unknown blood sample, aB = on admission blood sample, nB = non-fasting blood sample, sB = semi-fasting blood sample, HE = healthy controls, PB = population based cohort, SM = cohort of male smokers, NR = not reported</p></fn>
<fn id="t004fn002"><p>* per SD increase</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec025">
<title>Associations</title>
<p>One prospective study reported that risk for SAH decreased with an HR of 0.6 per SD unit increase in HDL in the subgroup under age 50 when they adjusted for age, sex, smoking, and alcohol consumption, but not for hypertension (<xref ref-type="table" rid="pone.0152568.t004">Table 4</xref>).[<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>] Another prospective study controlled for known risk factors and also excluded participants who were using cholesterol-lowering medication.[<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] After exclusion, however, the association between HDL and SAH remained unchanged. One study, comprising only male smokers, reported a decreasing risk for SAH with increasing HDL values (≥0.84 mmol/l) in their prospective setup (<xref ref-type="table" rid="pone.0152568.t004">Table 4</xref>).[<xref ref-type="bibr" rid="pone.0152568.ref029">29</xref>] The only retrospective study focusing on lipoprotein subtypes used on-admission measurements, controlled for known risk factors for SAH, and found no significant associations between HDL, ApoB, and SAH [<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>] (<xref ref-type="table" rid="pone.0152568.t004">Table 4</xref>).</p>
</sec>
</sec>
<sec id="sec026">
<title>Risk of bias and power analyses</title>
<sec id="sec027">
<title>Prospective studies</title>
<p>Of the 12[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>–<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>–<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] studies, only 2[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] had a low risk of bias; those 2 had a sufficient number of SAHs, included outside hospital sudden deaths, comprehensive risk factor control, analysis by sex, wide TC range, unlikely selection bias, sufficient accuracy (validation) of diagnosis, unlikely measurement bias, and low risk for reverse causality “<xref ref-type="fig" rid="pone.0152568.g002">Fig 2</xref>”. In addition, although one[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>] study met these criteria, all participants had very high TC levels; we thus determined that it had an unclear risk of bias. Nine studies[<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0152568.ref007">7</xref>,<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>–<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] had a high risk of bias because of limitations in the aforementioned criteria “<xref ref-type="fig" rid="pone.0152568.g002">Fig 2</xref>”. Moreover, power calculations suggested that only three[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>,<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] studies were able to detect significant associations between high TC and SAH (<xref ref-type="table" rid="pone.0152568.t003">Table 3</xref>).</p>
<fig id="pone.0152568.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0152568.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Risk of bias.</title>
<p>Classification of risk of bias and sources of bias in all studies.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0152568.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec028">
<title>Retrospective and low-TC studies</title>
<p>All nine[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0152568.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>,<xref ref-type="bibr" rid="pone.0152568.ref026">26</xref>] retrospective and eight[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>–<xref ref-type="bibr" rid="pone.0152568.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>] low-TC studies had a high risk of bias because of limitations in the aforementioned criteria “<xref ref-type="fig" rid="pone.0152568.g002">Fig 2</xref>”.</p>
</sec>
<sec id="sec029">
<title>Small studies</title>
<p>Since small studies tend to combine SAH and intracranial hemorrhage in a group of hemorrhagic stroke, we excluded them from the analysis.</p>
</sec>
<sec id="sec030">
<title>Studies on HDL</title>
<p>Of the four[<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>,<xref ref-type="bibr" rid="pone.0152568.ref029">29</xref>] studies, only one[<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] had a low risk of bias, because it met the aforementioned criteria.</p>
</sec>
<sec id="sec031">
<title>Meta-analysis</title>
<p>In addition to evident methodological differences among studies “<xref ref-type="fig" rid="pone.0152568.g002">Fig 2</xref>”, our meta-analysis showed also considerable heterogeneity. Heterogeneity among retrospective and Asian studies was high (I<sup>2</sup> = 79.5%-89.0%), and considerable in prospective studies (I<sup>2</sup> = 46.0%) “Figures A-D in <xref ref-type="supplementary-material" rid="pone.0152568.s002">S1 Figures</xref>”. Indisputably, meta-analysis on reviewed studies lacks justification. However, we performed a series of sensitivity analyses and selected the most similar studies for meta-analysis.</p>
<p>A meta-analysis limited to prospective studies with comparable wide TC groups, major limitations only in an analysis by sex and exclusion of certain SAH types,[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>,<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] showed moderate evidence that high TC elevates SAH risk with an RR of 1.33 “Figure E in <xref ref-type="supplementary-material" rid="pone.0152568.s002">S1 Figures</xref>”.</p>
<p>The meta-analysis including only retrospective studies with TC values measured in an acute phase[<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0152568.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>] showed no association between TC and SAH “Figure F in <xref ref-type="supplementary-material" rid="pone.0152568.s002">S1 Figures</xref>”. Meta-analysis including only studies which obtained TC values using interviews[<xref ref-type="bibr" rid="pone.0152568.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0152568.ref026">26</xref>] showed low TC as risk factor (RR 0.42) “Figure G in <xref ref-type="supplementary-material" rid="pone.0152568.s002">S1 Figures</xref>”. The sensitivity analysis included a small number of studies, and has unreliable heterogeneity estimates.</p>
</sec>
</sec>
</sec>
<sec id="sec032" sec-type="conclusions">
<title>Discussion</title>
<p>Some relatively high-quality evidence[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] suggests that high TC is a risk factor for SAH in men questioning the current understanding of SAH epidemiology. The role of HDL remained unresolved. [<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] Only one[<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>] retrospective study focused on associations between ApoB and SAH, but found none, whereas none studied LDL. Meta-analyses[<xref ref-type="bibr" rid="pone.0152568.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0152568.ref015">15</xref>] did not find strong associations between SAH and TC. However, they did not include extensive risk-of-bias analyses and, therefore may have failed to uncover sources of heterogeneity in the studies included.</p>
<p>Internal quality of SAH risk factor studies varies considerably, as most have significant methodological shortages and gaps in reporting. Five studies[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>–<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>] reported high TC, six[<xref ref-type="bibr" rid="pone.0152568.ref007">7</xref>–<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>] low TC, and ten others[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>,<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>–<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0152568.ref026">26</xref>–<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] neither one as increasing risk for SAH. Of all 12[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>–<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0152568.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0152568.ref027">27</xref>–<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] prospective studies, 3[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>,<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] had sufficient statistical power to detect associations between high TC and SAH. Of all 21 studies,[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0152568.ref012">12</xref>,<xref ref-type="bibr" rid="pone.0152568.ref022">22</xref>–<xref ref-type="bibr" rid="pone.0152568.ref030">30</xref>] only 2[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] had a low risk of bias. According to the classical Hills criteria of causality,[<xref ref-type="bibr" rid="pone.0152568.ref032">32</xref>] the two studies also had convincing temporality, biological gradient, plausibility, coherence, and analogy. These studies also included outside hospital SAH deaths. Both originated from the FINNRISK cohort but from different study groups. The most recent[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>] included more SAH cases and found stronger associations between elevated TC and SAH. Also sensitivity analysis including prospective studies (with comparable TC levels and only few limitations) supported the view that elevated TC associates with SAH risk. As TC is a well-known risk factor for cardiovascular diseases in general,[<xref ref-type="bibr" rid="pone.0152568.ref016">16</xref>] and atherosclerotic changes are commonly found in aneurysm walls,[<xref ref-type="bibr" rid="pone.0152568.ref033">33</xref>] the results for TC seem reasonable. Analysis of low-TC studies separately provided no support for the hypothesis of a U-shaped risk curve.</p>
<p>The recent low-risk-of-bias study suggested[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>] that TC levels over 5.6mmol/l elevate risk of SAH with HR of approximately 2 in men. Based on the varying prevalence (between 17% and 55%) of hypercholesterolemia worldwide,[<xref ref-type="bibr" rid="pone.0152568.ref034">34</xref>] the HR of 2 in men translates into PAR estimates ranging from 17% to 35%. The PAR of hypercholesterolemia in men can reach up to 35% in Europe, and up to 32% in the USA. Because TC levels are increasing in a number of countries,[<xref ref-type="bibr" rid="pone.0152568.ref035">35</xref>] PAR of hypercholesterolemia is likely to increase especially in developing countries. The recent low-risk-of-bias study reported HRs of 2.53 and 1.23 for smoking and hypertension in men. [<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>] With a prevalence estimate of 25% for smoking and 41% for hypertension, the HRs translate into PARs of 28% and 9% in men. Thus, TC may significantly contribute to the SAH incidence among men, and to the difference in risk-factor profiles between sexes.</p>
<p>TC and LDL levels are well-documented risk factors for other cardiovascular diseases (CVDs), whereas HDL is generally considered a protective risk indicator.[<xref ref-type="bibr" rid="pone.0152568.ref016">16</xref>] The role of a high LDL is considered to be causal, whereas the causal nature of the HDL association has been questioned.[<xref ref-type="bibr" rid="pone.0152568.ref036">36</xref>–<xref ref-type="bibr" rid="pone.0152568.ref038">38</xref>] Furthermore, the influence of these factors on CVDs may differ by sex[<xref ref-type="bibr" rid="pone.0152568.ref039">39</xref>,<xref ref-type="bibr" rid="pone.0152568.ref040">40</xref>] because premenopausal women are also at lower risk for CVDs than are age-matched men.[<xref ref-type="bibr" rid="pone.0152568.ref016">16</xref>] Physiological changes during menopause elevate risk for CVDs,[<xref ref-type="bibr" rid="pone.0152568.ref041">41</xref>] when TC and LDL levels start to rise at its beginning and reach their peak at approximately age 60.[<xref ref-type="bibr" rid="pone.0152568.ref039">39</xref>] At the same time, HDL decreases and triglycerides increase, making the lipid profile more unfavorable, thus elevating risk for CVDs, especially in women.[<xref ref-type="bibr" rid="pone.0152568.ref039">39</xref>] Of those included, two[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref008">8</xref>] prospective studies reporting age-group SAH incidences, further stratified by sex, showed SAH incidence in women to surpass male incidence at age 65 and above. TC levels often being low in premenopausal women may in part explain why associations between TC and SAH are difficult to discover. This emphasizes the importance of analyzing and representing TC associations by sex and age and indicates that future SAH studies should focus on the role of TC in both pre- and postmenopausal women separately.</p>
<p>Prospective follow-up studies require a significant number (approx. 270 000) of person-years and optimally over 35 SAHs for each sex per TC subgroup to reliably study associations between TC levels and risk for SAH. In addition, because roughly 20% of SAH patients die away from hospitals or in emergency rooms,[<xref ref-type="bibr" rid="pone.0152568.ref042">42</xref>] and are thus excluded from most studies, even more person-years may be necessary. Only four[<xref ref-type="bibr" rid="pone.0152568.ref001">1</xref>,<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0152568.ref029">29</xref>] Finnish and one Norwegian[<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>] population-based studies reported in their analyses inclusion of sudden deaths. Furthermore, TC values should be analyzed as a continuous variable and should include adequate numbers of participants with TC below 5.0 mmol/l and above 6.5 mmol/l. As the median age at SAH is nowadays 60 years,[<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>] the study cohort should be of a rather high median age with a very long follow-up. Even then, reliable studies on TC are nowadays very challenging to conduct, as a high proportion of those with hypercholesterolemia use statins. A recent retrospective study [<xref ref-type="bibr" rid="pone.0152568.ref043">43</xref>] relying on administrative data suggested that statin use in elderly patients with unruptured intracranial aneurysms does not affect the incidence rate of SAH. However, the study did not report TC levels at baseline or after statin treatment, and did not stratify the results by sex. All these factors considered, it is clear that discovering the epidemiological role of TC in SAH is challenging; relatively small and short-term studies need cautious interpretation.</p>
<p>One of the most important shortcomings in the prospective cohort studies reviewed is their lack of longitudinal follow-up data; changes in risk-factor profile during the study period may therefore distort and confound association analyses. For example, in prospective studies from Norway[<xref ref-type="bibr" rid="pone.0152568.ref002">2</xref>] and Finland,[<xref ref-type="bibr" rid="pone.0152568.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0152568.ref006">6</xref>] TC levels were measured 6 (mean) and 12 (median) years before SAH. As TC values have been a target of intensive drug and diet therapies during recent decades,[<xref ref-type="bibr" rid="pone.0152568.ref016">16</xref>] it is likely that baseline values had changed during follow-ups. Indeed, since the 1970s, when the study surveys began, the decline in TC of the Finnish population has been rapid, [<xref ref-type="bibr" rid="pone.0152568.ref044">44</xref>] and thus the risk estimates for TC levels may be unreliable. However, these modifications can only underestimate the role of high TC levels as a risk factor for SAH, making any associations between TC and SAH only decrease or disappear.</p>
<p>The reliability of retrospective studies in finding new risk factors for SAH is generally limited, not only because all outside hospital deaths are excluded from analyses, but also because of the evident risk of measurement bias when risk factors are measured by interview or after SAH. This was also evident in our sensitivity analyses, which included only on admission TC measurements or measurements by interview. Studies which measured TC by interview suggested that low TC elevates SAH risk. As TC levels may decrease during and after SAH,[<xref ref-type="bibr" rid="pone.0152568.ref045">45</xref>,<xref ref-type="bibr" rid="pone.0152568.ref046">46</xref>] all studies which measure TC on admission or within days after SAH are prone to reverse causality. This view is consistent with the results of the retrospective study[<xref ref-type="bibr" rid="pone.0152568.ref009">9</xref>] reporting TC as a risk factor for aneurysm formation but not for SAH. In addition, selection bias may weaken the generalizability of hospital-based studies by limiting the inclusion of patients with low TC in their control groups. Indeed, those retrospective studies[<xref ref-type="bibr" rid="pone.0152568.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0152568.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0152568.ref025">25</xref>] that reported high TC as leading to increased risk for SAH, used other emergency room patients or healthy people as control groups.</p>
<p>Our review has a few shortcomings. First, we may have missed some relevant publications due to indexing errors and limitations in the search strategy. Our search strategy, however, yielded 21 reviewed studies whereas the three earlier systematic reviews on this topic comprised only 7,[<xref ref-type="bibr" rid="pone.0152568.ref015">15</xref>] 6,[<xref ref-type="bibr" rid="pone.0152568.ref013">13</xref>] and 3[<xref ref-type="bibr" rid="pone.0152568.ref014">14</xref>] studies with over 50 SAH cases. Second, the review includes study by two authors (M.K. and J.K.), making it possible that unintentional conflict of interest has biased risk-of-bias estimations. We tried to avoid this with an established and public study protocol registered in the PROSPERO. Despite this, readers need to take this into consideration when evaluating the presented evidence. Third, a reliable meta-analysis, one which could have elucidated the role of TC in SAH, was impossible due to methodological differences and lack of the necessary additional data.</p>
</sec>
<sec id="sec033" sec-type="conclusions">
<title>Conclusion</title>
<p>Elevated TC levels may elevate risk for SAH among men, and therefore lipid profile should perhaps be taken into account when assessing risk for SAH in men. No convincing evidence exist that low TC elevates risk for SAH. Apart from diabetes and obesity, the risk-factor profile of SAH resembles that of other CVDs, at least in men.</p>
</sec>
<sec id="sec034">
<title>Supporting Information</title>
<supplementary-material id="pone.0152568.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0152568.s001" xlink:type="simple">
<label>S1 Cohorts</label>
<caption>
<title>Description of cohorts used in prospective studies.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0152568.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0152568.s002" xlink:type="simple">
<label>S1 Figures</label>
<caption>
<title>Meta-analysis and sensitivity analyses.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0152568.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0152568.s003" xlink:type="simple">
<label>S1 Methods</label>
<caption>
<title>Search strategy and protocol.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0152568.s004" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0152568.s004" xlink:type="simple">
<label>S1 PRISMA Checklist</label>
<caption>
<title/>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0152568.s005" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0152568.s005" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Cholesterol measurement protocols used in studies reviewed.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We appreciate James Neaton and Marie Sandvei´s providing additional information about their studies. We thank Jari Haukka and Marja-Liisa Lindbohm for critical revisions and Tiina Heino for advice in search protocol, and Carolyn Brimley Norris for language revision. We also thank Liang He, Teemu Hermunen, Joonas Kirsi, and Siamak Bidel for translations.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0152568.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Knekt</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Reunanen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Aho</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Heliovaara</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rissanen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Aromaa</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Risk factors for subarachnoid hemorrhage in a longitudinal population study</article-title>. <source>J Clin Epidemiol</source> <year>1991</year>;<volume>44</volume>(<issue>9</issue>):<fpage>933</fpage>–<lpage>939</lpage>. <object-id pub-id-type="pmid">1890435</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sandvei</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Lindekleiv</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Romundstad</surname> <given-names>PR</given-names></name>, <name name-style="western"><surname>Muller</surname> <given-names>TB</given-names></name>, <name name-style="western"><surname>Vatten</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Ingebrigtsen</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Risk factors for aneurysmal subarachnoid hemorrhage—BMI and serum lipids: 11-year follow-up of the HUNT and the Tromso Study in Norway</article-title>. <source>Acta Neurol Scand</source> <year>2012</year> <month>Jun</month>;<volume>125</volume>(<issue>6</issue>):<fpage>382</fpage>–<lpage>388</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1600-0404.2011.01578.x" xlink:type="simple">10.1111/j.1600-0404.2011.01578.x</ext-link></comment> <object-id pub-id-type="pmid">21793808</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Korja</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Silventoinen</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Laatikainen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Jousilahti</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Salomaa</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Hernesniemi</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Risk factors and their combined effects on the incidence rate of subarachnoid hemorrhage—a population-based cohort study</article-title>. <source>PLoS One</source> <year>2013</year> <month>Sep</month> <day>9</day>;<volume>8</volume>(<issue>9</issue>):<fpage>e73760</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0073760" xlink:type="simple">10.1371/journal.pone.0073760</ext-link></comment> <object-id pub-id-type="pmid">24040058</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Inagawa</surname> <given-names>T</given-names></name>. <article-title>Risk factors for aneurysmal subarachnoid hemorrhage in patients in Izumo City, Japan</article-title>. <source>J Neurosurg</source> <year>2005</year> <month>Jan</month>;<volume>102</volume>(<issue>1</issue>):<fpage>60</fpage>–<lpage>67</lpage>. <object-id pub-id-type="pmid">15658097</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Koh</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Koh</surname> <given-names>SY</given-names></name>. <article-title>Risk factors for hemorrhagic stroke in Wonju, Korea</article-title>. <source>Yonsei Med J</source> <year>1998</year> <month>Jun</month>;<volume>39</volume>(<issue>3</issue>):<fpage>229</fpage>–<lpage>235</lpage>. <object-id pub-id-type="pmid">9664827</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Tuomilehto</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Jousilahti</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Antikainen</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>G</given-names></name>. <article-title>Total and high-density lipoprotein cholesterol and stroke risk</article-title>. <source>Stroke</source> <year>2012</year> <month>Jul</month>;<volume>43</volume>(<issue>7</issue>):<fpage>1768</fpage>–<lpage>1774</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/STROKEAHA.111.646778" xlink:type="simple">10.1161/STROKEAHA.111.646778</ext-link></comment> <object-id pub-id-type="pmid">22496337</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gatchev</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Rastam</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lindberg</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Gullberg</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Eklund</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Isacsson</surname> <given-names>SO</given-names></name>. <article-title>Subarachnoid hemorrhage, cerebral hemorrhage, and serum cholesterol concentration in men and women</article-title>. <source>Ann Epidemiol</source> <year>1993</year> <month>Jul</month>;<volume>3</volume>(<issue>4</issue>):<fpage>403</fpage>–<lpage>409</lpage>. <object-id pub-id-type="pmid">8275217</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Suzuki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Izumi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sakamoto</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Hayashi</surname> <given-names>M</given-names></name>. <article-title>Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan</article-title>. <source>Cerebrovasc Dis</source> <year>2011</year>;<volume>31</volume>(<issue>1</issue>):<fpage>100</fpage>–<lpage>106</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000321506" xlink:type="simple">10.1159/000321506</ext-link></comment> <object-id pub-id-type="pmid">21079399</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Inagawa</surname> <given-names>T</given-names></name>. <article-title>Risk factors for the formation and rupture of intracranial saccular aneurysms in Shimane, Japan</article-title>. <source>World Neurosurg</source> <year>2010</year> <month>Mar</month>;<volume>73</volume>(<issue>3</issue>):<fpage>155</fpage>–<lpage>64</lpage>; discussion e23. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.surneu.2009.03.007" xlink:type="simple">10.1016/j.surneu.2009.03.007</ext-link></comment> <object-id pub-id-type="pmid">20860953</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ohkuma</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Tabata</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Suzuki</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Islam</surname> <given-names>MS</given-names></name>. <article-title>Risk factors for aneurysmal subarachnoid hemorrhage in Aomori, Japan</article-title>. <source>Stroke</source> <year>2003</year> <month>Jan</month>;<volume>34</volume>(<issue>1</issue>):<fpage>96</fpage>–<lpage>100</lpage>. <object-id pub-id-type="pmid">12511757</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tokuda</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Stein</surname> <given-names>GH</given-names></name>. <article-title>Serum lipids as protective factors for subarachnoid hemorrhage</article-title>. <source>J Clin Neurosci</source> <year>2005</year> <month>Jun</month>;<volume>12</volume>(<issue>5</issue>):<fpage>538</fpage>–<lpage>541</lpage>. <object-id pub-id-type="pmid">15975790</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vlak</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Rinkel</surname> <given-names>GJ</given-names></name>, <name name-style="western"><surname>Greebe</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Greving</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Algra</surname> <given-names>A</given-names></name>. <article-title>Lifetime risks for aneurysmal subarachnoid haemorrhage: multivariable risk stratification</article-title>. <source>J Neurol Neurosurg Psychiatry</source> <year>2013</year> <month>Jun</month>;<volume>84</volume>(<issue>6</issue>):<fpage>619</fpage>–<lpage>623</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/jnnp-2012-303783" xlink:type="simple">10.1136/jnnp-2012-303783</ext-link></comment> <object-id pub-id-type="pmid">23355806</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feigin</surname> <given-names>VL</given-names></name>, <name name-style="western"><surname>Rinkel</surname> <given-names>GJ</given-names></name>, <name name-style="western"><surname>Lawes</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Algra</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bennett</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>van Gijn</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies</article-title>. <source>Stroke</source> <year>2005</year> <month>Dec</month>;<volume>36</volume>(<issue>12</issue>):<fpage>2773</fpage>–<lpage>2780</lpage>. <object-id pub-id-type="pmid">16282541</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Teunissen</surname> <given-names>LL</given-names></name>, <name name-style="western"><surname>Rinkel</surname> <given-names>GJ</given-names></name>, <name name-style="western"><surname>Algra</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>van Gijn</surname> <given-names>J</given-names></name>. <article-title>Risk factors for subarachnoid hemorrhage: a systematic review</article-title>. <source>Stroke</source> <year>1996</year> <month>Mar</month>;<volume>27</volume>(<issue>3</issue>):<fpage>544</fpage>–<lpage>549</lpage>. <object-id pub-id-type="pmid">8610327</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Dong</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Qi</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Hou</surname> <given-names>L</given-names></name>. <article-title>Cholesterol Levels and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis</article-title>. <source>Stroke</source> <year>2013</year> <month>May</month> <day>23</day>.</mixed-citation></ref>
<ref id="pone.0152568.ref016"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 Dec 17;106(25):3143–3421.</mixed-citation></ref>
<ref id="pone.0152568.ref017"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Higgins JPT, Green S (editors). <italic>Cochrane Handbook for Systematic Reviews of Interventions</italic> Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from <ext-link ext-link-type="uri" xlink:href="http://www.cochrane-handbook.org" xlink:type="simple">www.cochrane-handbook.org</ext-link>. Version 5.0.2 ed.; 2009.</mixed-citation></ref>
<ref id="pone.0152568.ref018"><label>18</label><mixed-citation publication-type="other" xlink:type="simple"><italic>Critical Appraisal Skills Programme (CASP)</italic>. CASP Checklists (<ext-link ext-link-type="uri" xlink:href="http://media.wix.com/ugd/dded87_e37a4ab637fe46a0869f9f977dacf134.pdf" xlink:type="simple">http://media.wix.com/ugd/dded87_e37a4ab637fe46a0869f9f977dacf134.pdf</ext-link>) Oxford CASP 2014.</mixed-citation></ref>
<ref id="pone.0152568.ref019"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Newcastle-Ottawa Scale (NOS). <ext-link ext-link-type="uri" xlink:href="http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" xlink:type="simple">http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</ext-link>.</mixed-citation></ref>
<ref id="pone.0152568.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shea</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Grimshaw</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Wells</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Boers</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Andersson</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Hamel</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews</article-title>. <source>BMC Med Res Methodol</source> <year>2007</year> <month>Feb</month> <day>15</day>;<volume>7</volume>:<fpage>10</fpage>. <object-id pub-id-type="pmid">17302989</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moher</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Liberati</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>, <collab>PRISMA Group</collab>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>PLoS Med</source> <year>2009</year> <month>Jul</month> <day>21</day>;<volume>6</volume>(<issue>7</issue>):<fpage>e1000097</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.1000097" xlink:type="simple">10.1371/journal.pmed.1000097</ext-link></comment> <object-id pub-id-type="pmid">19621072</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Suh</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Jee</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>HC</given-names></name>, <name name-style="western"><surname>Nam</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>IS</given-names></name>, <name name-style="western"><surname>Appel</surname> <given-names>LJ</given-names></name>. <article-title>Low serum cholesterol and haemorrhagic stroke in men: Korea Medical Insurance Corporation Study</article-title>. <source>Lancet</source> <year>2001</year> <month>Mar</month> <day>24</day>;<volume>357</volume>(<issue>9260</issue>):<fpage>922</fpage>–<lpage>925</lpage>. <object-id pub-id-type="pmid">11289349</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Broderick</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Viscoli</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Brott</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kernan</surname> <given-names>WN</given-names></name>, <name name-style="western"><surname>Brass</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Feldmann</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable</article-title>. <source>Stroke</source> <year>2003</year> <month>Jun</month>;<volume>34</volume>(<issue>6</issue>):<fpage>1375</fpage>–<lpage>1381</lpage>. <object-id pub-id-type="pmid">12764233</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Neaton</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Wentworth</surname> <given-names>DN</given-names></name>, <name name-style="western"><surname>Cutler</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Stamler</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kuller</surname> <given-names>L</given-names></name>. <article-title>Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group</article-title>. <source>Ann Epidemiol</source> <year>1993</year> <month>Sep</month>;<volume>3</volume>(<issue>5</issue>):<fpage>493</fpage>–<lpage>499</lpage>. <object-id pub-id-type="pmid">8167825</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adamson</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Humphries</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Ostergaard</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Voldby</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Richards</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Powell</surname> <given-names>JT</given-names></name>. <article-title>Are cerebral aneurysms atherosclerotic?</article-title> <source>Stroke</source> <year>1994</year> <month>May</month>;<volume>25</volume>(<issue>5</issue>):<fpage>963</fpage>–<lpage>966</lpage>. <object-id pub-id-type="pmid">8165691</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Canhao</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Pinto</surname> <given-names>AN</given-names></name>, <name name-style="western"><surname>Ferro</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ferro</surname> <given-names>JM</given-names></name>. <article-title>Smoking and aneurysmal subarachnoid haemorrhage: a case-control study</article-title>. <source>J Cardiovasc Risk</source> <year>1994</year> <month>Aug</month>;<volume>1</volume>(<issue>2</issue>):<fpage>155</fpage>–<lpage>158</lpage>. <object-id pub-id-type="pmid">7606628</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cui</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Iso</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Toyoshima</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Date</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Yamamoto</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kikuchi</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Serum total cholesterol levels and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study</article-title>. <source>Atherosclerosis</source> <year>2007</year> <month>Oct</month>;<volume>194</volume>(<issue>2</issue>):<fpage>415</fpage>–<lpage>420</lpage>. <object-id pub-id-type="pmid">16970954</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iso</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Jacobs</surname> <given-names>DR</given-names> <suffix>Jr</suffix></name>, <name name-style="western"><surname>Wentworth</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Neaton</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Cohen</surname> <given-names>JD</given-names></name>. <article-title>Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial</article-title>. <source>N Engl J Med</source> <year>1989</year> <month>Apr</month> <day>6</day>;<volume>320</volume>(<issue>14</issue>):<fpage>904</fpage>–<lpage>910</lpage>. <object-id pub-id-type="pmid">2619783</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leppala</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Virtamo</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Fogelholm</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Albanes</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Heinonen</surname> <given-names>OP</given-names></name>. <article-title>Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants</article-title>. <source>Stroke</source> <year>1999</year> <month>Dec</month>;<volume>30</volume>(<issue>12</issue>):<fpage>2535</fpage>–<lpage>2540</lpage>. <object-id pub-id-type="pmid">10582974</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tirschwell</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>NL</given-names></name>, <name name-style="western"><surname>Heckbert</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Lemaitre</surname> <given-names>RN</given-names></name>, <name name-style="western"><surname>Longstreth</surname> <given-names>WT</given-names> <suffix>Jr</suffix></name>, <name name-style="western"><surname>Psaty</surname> <given-names>BM</given-names></name>. <article-title>Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups</article-title>. <source>Neurology</source> <year>2004</year> <month>Nov</month> <day>23</day>;<volume>63</volume>(<issue>10</issue>):<fpage>1868</fpage>–<lpage>1875</lpage>. <object-id pub-id-type="pmid">15557504</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kettunen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tukiainen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sarin</surname> <given-names>AP</given-names></name>, <name name-style="western"><surname>Ortega-Alonso</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tikkanen</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Lyytikainen</surname> <given-names>LP</given-names></name>, <etal>et al</etal>. <article-title>Genome-wide association study identifies multiple loci influencing human serum metabolite levels</article-title>. <source>Nat Genet</source> <year>2012</year> <month>Jan</month> <day>29</day>;<volume>44</volume>(<issue>3</issue>):<fpage>269</fpage>–<lpage>276</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.1073" xlink:type="simple">10.1038/ng.1073</ext-link></comment> <object-id pub-id-type="pmid">22286219</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hill</surname> <given-names>AB</given-names></name>. <article-title>The Environment and Disease: Association Or Causation?</article-title> <source>Proc R Soc Med</source> <year>1965</year> <month>May</month>;<volume>58</volume>:<fpage>295</fpage>–<lpage>300</lpage>. <object-id pub-id-type="pmid">14283879</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Frosen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tulamo</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Paetau</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Laaksamo</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Korja</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Laakso</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Saccular intracranial aneurysm: pathology and mechanisms</article-title>. <source>Acta Neuropathol</source> <year>2012</year> <month>Jun</month>;<volume>123</volume>(<issue>6</issue>):<fpage>773</fpage>–<lpage>786</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00401-011-0939-3" xlink:type="simple">10.1007/s00401-011-0939-3</ext-link></comment> <object-id pub-id-type="pmid">22249619</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref034"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization. Description of the global burden of NCDs, their risk factors and determinants. Global status report on noncommunicable diseases 201 April 2011:1–176.</mixed-citation></ref>
<ref id="pone.0152568.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Farzadfar</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Finucane</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Danaei</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Pelizzari</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Cowan</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Paciorek</surname> <given-names>CJ</given-names></name>, <etal>et al</etal>. <article-title>National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants</article-title>. <source>Lancet</source> <year>2011</year> <month>Feb</month> <day>12</day>;<volume>377</volume>(<issue>9765</issue>):<fpage>578</fpage>–<lpage>586</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(10)62038-7" xlink:type="simple">10.1016/S0140-6736(10)62038-7</ext-link></comment> <object-id pub-id-type="pmid">21295847</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haase</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Tybjaerg-Hansen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Qayyum</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Schou</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Nordestgaard</surname> <given-names>BG</given-names></name>, <name name-style="western"><surname>Frikke-Schmidt</surname> <given-names>R</given-names></name>. <article-title>LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals</article-title>. <source>J Clin Endocrinol Metab</source> <year>2012</year> <month>Feb</month>;<volume>97</volume>(<issue>2</issue>):<fpage>E248</fpage>–<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1210/jc.2011-1846" xlink:type="simple">10.1210/jc.2011-1846</ext-link></comment> <object-id pub-id-type="pmid">22090275</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holmes</surname> <given-names>MV</given-names></name>, <name name-style="western"><surname>Asselbergs</surname> <given-names>FW</given-names></name>, <name name-style="western"><surname>Palmer</surname> <given-names>TM</given-names></name>, <name name-style="western"><surname>Drenos</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Lanktree</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Nelson</surname> <given-names>CP</given-names></name>, <etal>et al</etal>. <article-title>Mendelian randomization of blood lipids for coronary heart disease</article-title>. <source>Eur Heart J</source> <year>2015</year> <month>Mar</month> <day>1</day>;<volume>36</volume>(<issue>9</issue>):<fpage>539</fpage>–<lpage>550</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/eurheartj/eht571" xlink:type="simple">10.1093/eurheartj/eht571</ext-link></comment> <object-id pub-id-type="pmid">24474739</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Voight</surname> <given-names>BF</given-names></name>, <name name-style="western"><surname>Peloso</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Orho-Melander</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Frikke-Schmidt</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Barbalic</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Jensen</surname> <given-names>MK</given-names></name>, <etal>et al</etal>. <article-title>Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study</article-title>. <source>Lancet</source> <year>2012</year> <month>Aug</month> <day>11</day>;<volume>380</volume>(<issue>9841</issue>):<fpage>572</fpage>–<lpage>580</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(12)60312-2" xlink:type="simple">10.1016/S0140-6736(12)60312-2</ext-link></comment> <object-id pub-id-type="pmid">22607825</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Evangelista</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>McLaughlin</surname> <given-names>MA</given-names></name>. <article-title>Review of cardiovascular risk factors in women</article-title>. <source>Gend Med</source> <year>2009</year>;<volume>6</volume> <issue>Suppl 1</issue>:<fpage>17</fpage>–<lpage>36</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.genm.2009.02.004" xlink:type="simple">10.1016/j.genm.2009.02.004</ext-link></comment> <object-id pub-id-type="pmid">19318217</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tan</surname> <given-names>YY</given-names></name>, <name name-style="western"><surname>Gast</surname> <given-names>GC</given-names></name>, <name name-style="western"><surname>van der Schouw</surname> <given-names>YT</given-names></name>. <article-title>Gender differences in risk factors for coronary heart disease</article-title>. <source>Maturitas</source> <year>2010</year> <month>Feb</month>;<volume>65</volume>(<issue>2</issue>):<fpage>149</fpage>–<lpage>160</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.maturitas.2009.09.023" xlink:type="simple">10.1016/j.maturitas.2009.09.023</ext-link></comment> <object-id pub-id-type="pmid">19897327</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Auro</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Joensuu</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Fischer</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kettunen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Salo</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mattsson</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>A metabolic view on menopause and ageing</article-title>. <source>Nat Commun</source> <year>2014</year> <month>Aug</month> <day>21</day>;<volume>5</volume>:<fpage>4708</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncomms5708" xlink:type="simple">10.1038/ncomms5708</ext-link></comment> <object-id pub-id-type="pmid">25144627</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Korja</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Silventoinen</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Laatikainen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Jousilahti</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Salomaa</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Kaprio</surname> <given-names>J</given-names></name>. <article-title>Cause-specific mortality of 1-year survivors of subarachnoid hemorrhage</article-title>. <source>Neurology</source> <year>2013</year> <month>Jan</month> <day>29</day>;<volume>80</volume>(<issue>5</issue>):<fpage>481</fpage>–<lpage>486</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1212/WNL.0b013e31827f0fb5" xlink:type="simple">10.1212/WNL.0b013e31827f0fb5</ext-link></comment> <object-id pub-id-type="pmid">23303843</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bekelis</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>MacKenzie</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Roberts</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Skinner</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Statins and subarachnoid hemorrhage in Medicare patients with unruptured cerebral aneurysms</article-title>. <source>Int J Stroke</source> <year>2015</year> <month>Oct</month>;<volume>10</volume> <issue>Suppl A100</issue>:<fpage>38</fpage>–<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/ijs.12559" xlink:type="simple">10.1111/ijs.12559</ext-link></comment> <object-id pub-id-type="pmid">26120925</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Borodulin</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Vartiainen</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Peltonen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Jousilahti</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Juolevi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Laatikainen</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Forty-year trends in cardiovascular risk factors in Finland</article-title>. <source>Eur J Public Health</source> <year>2015</year> <month>Jun</month>;<volume>25</volume>(<issue>3</issue>):<fpage>539</fpage>–<lpage>546</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/eurpub/cku174" xlink:type="simple">10.1093/eurpub/cku174</ext-link></comment> <object-id pub-id-type="pmid">25422363</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aull</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lalouschek</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Schnider</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Sinzinger</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Uhl</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Zeiler</surname> <given-names>K</given-names></name>. <article-title>Dynamic changes of plasma lipids and lipoproteins in patients after transient ischemic attack or minor stroke</article-title>. <source>Am J Med</source> <year>1996</year> <month>Sep</month>;<volume>101</volume>(<issue>3</issue>):<fpage>291</fpage>–<lpage>298</lpage>. <object-id pub-id-type="pmid">8873491</object-id></mixed-citation></ref>
<ref id="pone.0152568.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Woo</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lam</surname> <given-names>CW</given-names></name>, <name name-style="western"><surname>Kay</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>HY</given-names></name>, <name name-style="western"><surname>Teoh</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Nicholls</surname> <given-names>MG</given-names></name>. <article-title>Acute and long-term changes in serum lipids after acute stroke</article-title>. <source>Stroke</source> <year>1990</year> <month>Oct</month>;<volume>21</volume>(<issue>10</issue>):<fpage>1407</fpage>–<lpage>1411</lpage>. <object-id pub-id-type="pmid">2219204</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>